MP53-13 IS DOMINANT TUMOR NODULE SIZE A SIGNIFICANT PREDICTOR OF ADVERSE OUTCOME IN PROSTATE CANCER? A STUDY OF 487 WHOLE MOUNT RADICAL PROSTATECTOMY CASES.
Laura Favazza(Henry Ford Health System), Nilesh Gupta(Henry Ford Health System), Craig Rogers(Norfolk and Norwich University Hospitals NHS Foundation Trust), Alpa B. Shah(Memorial Sloan Kettering Cancer Center), Hans Stricker(University Hospital of Bern), James O. Peabody(Henry Ford Hospital), Sean R. Williamson(Cleveland Clinic), Mani Menon(Henry Ford Hospital), Mireya Diaz‐Insua
Cited by 0
Related Papers
The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on Grading of Prostatic Carcinoma
|The American Journal of Surgical Pathology|2020|705
Rb Loss Is Characteristic of Prostatic Small Cell Neuroendocrine Carcinoma
|Clinical Cancer Research|2013|358
New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia
|Modern Pathology|2021|254